Feb 22, 2012 — In a reversal, a panel of experts is advising the Food and Drug Administration to approve Qnexa, a weight-loss pill, that was rejected in 2010. The potential benefits for overweight people exceed the risks, such as birth defects and increased heart rates, the panel determined.
Nov 10, 2011 — The drug, given by injection, isn't going to be on pharmacy shelves anytime soon. But it has now been seen to work in five different species — from mice to monkeys. A human test of the drug is set to begin soon.
Feb 1, 2011 — In a move that contradicted the advice of a panel of outside experts, the Food and Drug Administration will not consider approving the diet pill Contrave without a large study to determine its heart risks.